+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2015-09-14Number of Pages: 67

Tissue Engineered Skin Substitutes Market (by Type - Acellular, Cellular Allogeneic, Cellular Autologous, and Others; by Application - Burn Injury, Diabetic/Vascular Ulcer, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023

 

Tissue engineered skin substitutes are cellular and acellular materials that aid in the healing of damaged skin by releasing cytokines and growth factors at the wound site. Skin substitutes or artificial skin substitute are derived from human tissue, non-human tissue, synthetic materials, and combination of the above materials. This report studies the current scenario as well as future market potential for tissue engineered skin substitutes globally. This report comprises an elaborate executive summary, which includes a market snapshot that provides market dynamics of various segments and sub-segments that are included in the report in a precise manner. Moreover, executive summary comprises waterfall diagram, which reflects the market size of various segments in descending order.

A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global tissue engineered skin substitutes market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, Porter’s Five Forces analysis, and market share analysis by key players (%) operating in the tissue engineered skin substitutes market. 

Based on type, the global tissue engineered skin substitutes market has been segmented into acellular, cellular allogeneic, cellular autologous and others. The market for these types has been extensively analyzed based on consistency, effectiveness, and sales revenue of the various products developed by the manufacturers. The market size and forecast in terms of USD million for each type has been provided for the period from 2013 to 2023. The report on the tissue engineered skin substitutes market also provides compound annual growth rate (CAGR %) for each of the market segments mentioned above for the forecast period from 2015 to 2023, considering 2014 as the base year.

Based on application, the global tissue engineered skin substitutes market has been segmented into burn injury, diabetic/vascular ulcer and others. The market for these types has been extensively analyzed based on consistency, effectiveness, and sales revenue of the various products developed by the manufacturers. The market size and forecast in terms of USD million for each product (category) has been provided for the period from 2013 to 2023. The report on the tissue engineered skin substitutes market also provides compound annual growth rate (CAGR %) for each of the market segments mentioned above for the forecast period from 2015 to 2023, considering 2014 as the base year.

Geographically, the tissue engineered skin substitutes market has been categorized into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. The market size and forecast for each of these regions have been provided for the period from 2013 to 2023 along with CAGR (%) for the forecast period from 2013 to 2023. The research study also incorporates the competitive scenario of major players in these regions.

A list of recommendations has been provided for new entrants to help establish a strong presence and for existing market players to increase their market shares. The report concludes with the profiles of major players in the tissue engineered skin substitutes market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include 3M Health Care, BSN medical, Medtronic, Acelity, L.P., Inc., Mölnlycke Health and Integra LifeSciences Corporation. 

The global tissue engineered skin substitutes market is segmented as follows:

  • Global Tissue Engineered Skin Substitutes Market, by Type
    • Acellular
    • Cellular Allogeneic
    • Cellular Autologous
    • Others
  • Global Tissue Engineered Skin Substitutes Market, by Application
    • Burn Injury
    • Diabetic/Vascular Ulcer
    • Others
  • Global Tissue Engineered Skin Substitutes Market, by Geography
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K
      • Germany
      • Rest of Europe
    • Asia Pacific (APAC)
      • China
      • India
      • Rest of APAC
    • Latin America (LATAM)
      • Brazil
      • Mexico
      • Rest of LATAM
    • Middle East & Africa (MEA)
      • South Africa
      • Rest of MEA

 

Chapter 1 Preface
1.1 Overview
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 Comparative Analysis: Global Tissue Engineered Skin Substitutes Market, by Geography, 2014 and 2023 (Value %)
2.2 Global Tissue Engineered Skin Substitutes Market, by Type, 2014 (USD Million)
2.3 Market Snapshot: Global Tissue Engineered Skin Substitutes Market (2014 & 2023)

Chapter 3 Industry Analysis
3.1 Overview
3.2 Market Drivers
      3.2.1 Rise in Geriatric Population
      3.2.2 Increasing Incidence rate of Skin disorders
      3.2.3 Growing Medical tourism and medspas
3.3 Restraints
      3.3.1 Competitive Pricing and Equipment Costs
3.4 Opportunities
      3.4.1 Emerging Economies to Offer Sustained Growth Opportunities
      3.4.2 New Products, Services, and Device Development
3.5 Porter’s Five Force Analysis: Global Tissue Engineered Skin Substitutes Market
      3.5.1 Bargaining power of suppliers
      3.5.2 Bargaining power of buyers
      3.5.3 Threat of substitutes
      3.5.4 Threat of new entrants
      3.5.5 Competitive rivalry
3.6 Market Attractiveness Analysis: Global Tissue Engineered Skin Substitutes Market, by Geography
3.7 Competitive Landscape 
      3.8.1 Global Tissue Engineered Skin Substitute Market, by Key, Players, 2014 (%)

Chapter 4 Global Tissue Engineered Skin Substitutes Market Revenue, by Type
4.1 Overview
      4.1.1 Global Tissue Engineered Skin Substitutes Market Revenue, 2013–2023 (US$ Mn) 
4.2 Acellular Skin substitute
      4.2.1 Global Acellular Skin Substitutes Market Revenue, 2013–2023 (US$ Mn)
4.3 Cellular Allogeneic
      4.3.1 Global Cellular Allogeneic Skin Substitute Market Revenue, 2013 – 2023 (USD Million)
4.4 Cellular Autologous 
      4.4.1 Global Cellular Autologous Skin Substitute Market Revenue, 2013 – 2023 (USD Million)

Chapter 5 Global Tissue Engineered Skin Substitutes Market Revenue, by Application
5.1 Overview
      5.1.1 Global Tissue Engineered Skin Substitutes Market Revenue, by Application, 2013 – 2023 (USD Million)
5.2 Burns
      5.2.1 Global Burns Skin Substitute Market Revenue, 2013 – 2023 (USD Million)
5.3 Diabetic/Vascular Ulcers
      5.3.1 Global Diabetic/Vascular Ulcers Skin substitute Market Revenue, 2013 – 2023 (USD Million)
5.4 Others
      5.4.1 Global Others Skin substitute Market Revenue, 2013 – 2023 (USD Million)

Chapter 6 Global Tissue Engineered Skin Substitutes Market Revenue, by Geography
6.1 Overview
      6.1.1 Global Tissue Engineered Skin Substitutes Market Revenue, by Geography, 2013 – 2023 (USD Million)
6.2 North America
      6.2.1 North America Tissue Engineered Skin Substitutes Market Revenue, by Country, 2013 – 2023 (USD Million)
6.3 Europe
      6.3.1 Europe Tissue Engineered Skin Substitutes Market Revenue, by Country, 2013 – 2023 (USD Million)
6.4 Asia Pacific
      6.4.1 Asia Pacific Tissue Engineered Skin Substitutes Market Revenue, by Country, 2013 – 2023 (USD Million)
6.5 Latin America (LATAM)
      6.5.1 Latin Tissue Engineered Skin Substitutes Market Revenue, by Country, 2013 – 2023 (USD Million)
6.6 Middle East and Africa (MEA)
      6.6.1 Middle East Africa (MEA) Tissue Engineered Skin Substitutes Market Revenue, by Country, 2013 – 2023 (USD Million)

Chapter 7 Recommendations
7.1 Research and Development Initiatives to Penetrate in the Market
7.2 Sustaining Pricing Pressures in a Declining Global Economic Scenario

Chapter 8 Company Profiles
8.1 Acelity L.P., Inc.
8.2 BSN medical
8.3 Integra LifeSciences Corporation
8.4 Medtronic (Covidien)
8.5 Mölnlycke Health Care
8.6 Smith & Nephew plc
8.7 Organogenesis, Inc

 

Tissue engineered skin substitutes or artificial skin substitutes can be defined as bioengineered skin substitutes derived from human tissue, non-human tissue, synthetic materials, and composite of the above materials. Tissue engineered skin substitutes are made up of cells, the extracellular matrix, and combination of cells and matrices. These are mostly used for the treatment of burns, diabetic ulcers, vascular ulcers, and lacerations. Biological skin substitute is recognized as an ultimate standard for the treatment of burn, diabetic ulcer and vascular ulcers as it is easy-to-use, safe, and provides effective/permanent treatment in a short time span. In addition, rapidly increasing diabetic patients and vascular ulcer cases are likely to boost the global demand for tissue engineered skin substitutes. Rising sports injuries and rapidly growing obese population boosts demand for tissue engineered skin substitutes globally. However, lack of favorable reimbursement policies pertaining to the treatment of vascular disease and high risk of post-implementation infection associated with allogeneic skin substitutes is expected to restrict market growth. The global tissue engineered skin substitutes market was valued at USD 958.8 million in 2014 and is projected to reach USD 3,873.5 million by 2023, expanding at a CAGR of 17.2% from 2015 to 2023.  

Based on type, the global tissue engineered skin substitutes market has been segmented into acellular, cellular allogeneic, cellular autologous, and others. The acellular skin substitute segment accounted for the largest share and is anticipated to expand at the highest CAGR during the forecast period from 2015 to 2023. The dominance of this segment was primarily due to low cost, easy availability, and high demand for the products. Moreover, effective treatment result and growing preference for innovative and comfortable skin substitutes are the other factors supporting market growth.

Based on application, the global tissue engineered skin substitutes market has been segmented into burn Injury, diabetic ulcer/vascular ulcer, and others. The diabetic ulcer application segment accounted for the largest share in 2014. This is primarily due to high prevalence of diabetic ulcers and growing demand for biological skin substitutes for diabetic ulcer treatment. For instance, according to International Diabetes Federation (2014), around 387.0 million people are suffering from diabetes, of these around 25.0% of the patients are diagnosed with diabetic ulceration which require extensive healing time. Skin substitutes are the ultimate choice for patients suffering from acute diabetic ulcers. Hence, escalating number of diabetic patients is likely to fuel the growth of tissue engineered skin substitutes market. The diabetic ulcer application segment is anticipated to expand at the highest growth rate during the study period.

Geographically, North America was the largest market for tissue engineered skin substitutes in 2014. Increasing prevalence of vascular ulcers and rising demand for various advanced tissue engineered skin products propel the growth of the market in the region. For instance, the Centers for Disease Control and Prevention published a report in March 2015 which stated that approximately 900,000 people are affected by deep vein thrombosis (DVT) in the U.S. each year. Hence, rise in DVT cases is likely to boost demand for tissue engineered skin substitutes in North America.

The tissue engineered skin substitutes market in Asia Pacific is anticipated to witness the fastest growth rate during the forecast period as compared to North America and Europe. Increasing geriatric population in countries such as Japan, China, and Singapore have increased demand for accurate and reliable biological skin products, thereby driving the market in the region. Moreover, rising disposable income and increase in health care infrastructure in countries such as India, China, and Malaysia would support market growth. 

Major players operating in the global tissue engineered skin substitutes market include 3M Health Care, BSN medical, Medtronic, Acelity, L.P., Inc., Mölnlycke Health, and Integra LifeSciences Corporation.

global-tissue-engineered-skin-substitutes-market

 


A complete brochure for this research is available for download.

Interact with our pool of experienced analysts for any report related queries